CAPG promotes the proliferation of colorectal cancer cells by inhibiting ferroptosis (20), and ferroptosis activation may be a potential therapeutic strategy in hepatocellular carcinoma patients with high CAPG expression (21). The gene discussed is CAPG; the disease is hepatocellular carcinoma.